Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases

Drs Karpouzas and Husni have assembled a series of articles that address one of the most important issues facing our management of systemic rheumatic disease patients in the modern era, the prevention and (hopefully) successful identification and avoidance of cardiovascular morbidity and mortality. In the 1960s and 1970s, patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) actually died directly from the heart and vascular complications of their disease. This has been reversed.
Source: Rheumatic Disease Clinics of North America - Category: Rheumatology Authors: Tags: Foreword Source Type: research